Paragon Bioservices, Inc. — Form D
Paragon Bioservices, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-26. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-05-26
- Form: D
- Accession: 0001014100-17-000035
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $2.4M
- Minimum investment: $20K
- Investors: 9
- Date of first sale: 2017-05-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-287602
Issuer
- Name: Paragon Bioservices, Inc.
- CIK: 0001623394
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 801 W. BALTIMORE STREET, BALTIMORE, MD, 21201
- Phone: 410-975-4052
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Kapila Ratnam | Director | King of Prussia, PA |
| Peter Buzy | Director | Germantown, MD |
| Peter Buzy | Executive Officer | Germantown, MD |
| Robert Roche | Director | Baltimore, MD |
| Patrick Hervy | Director | Baltimore, MD |
| Donald Hughes | Director | Baltimore, MD |
| Marco Chacon | Director | Baltimore, MD |
| Marco Chacon | Executive Officer | Baltimore, MD |
| Christopher Kersey | Director | San Diego, CA |
Other filings by this issuer (3)
More